WallStreetZenWallStreetZen

NASDAQ: CTOR
Citius Oncology Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Citius Oncology earnings were -$42.5M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest CTOR earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$26.6M, up 380.8% from last quarter. For the last reported fiscal year 2025 ending Sep 30, 2025, CTOR reported annual earnings of -$24.8M, with 17.1% growth. The next CTOR earnings date is Aug 11, 2026.

CTOR earnings history

Current Revenue
$5.6M
Current Earnings
-$42.5M
Current Profit Margin
-757.6%

CTOR Return on Equity

Current Company
-99.5%
Current Industry
12%
Current Market
13.5%
CTOR's Return on Equity (-99.5%)... subscribe to Premium to read more.
High Return on Equity Performance

CTOR Return on Assets

Current Company
-42.2%
Current Industry
5%
CTOR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CTOR announces earnings.

CTOR Return on Capital Employed

Current Company
-99.44%
Current Industry
11.3%
CTOR's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CTOR vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CTOR-$41.65M-$42.51MN/A-$0.47
INCR-$3.84M-$11.90MN/A-$0.22
TLPH-$14.25M-$14.25MN/A-$0.28
IXHL-$48.16M-$48.41MN/A-$16.85
SCYX-$24.52M-$24.52MN/A-$3.84
View Top Pharmaceutical Stocks

CTOR earnings dates

Next earnings date
Aug 11, 2026

Citius Oncology Earnings Reports & History FAQ

What were Citius Oncology's earnings last quarter?

Citius Oncology (NASDAQ: CTOR) reported Q1 2026 earnings per share (EPS) of -$0.27, up 145.45% year over year. Total CTOR earnings for the quarter were -$26.61 million. In the same quarter last year, Citius Oncology's earnings per share (EPS) was -$0.11.

If you're new to stock investing, here's how to buy Citius Oncology stock.

When does Citius Oncology report earnings?

The next CTOR earnings call is Invalid Date. Add CTOR to your watchlist to be reminded of Citius Oncology's next earnings date.

What was CTOR's earnings growth in the past year?

As of Citius Oncology's earnings date in Q3 2026, Citius Oncology's earnings has grown year over year. CTOR earnings in the past year totalled -$42.51 million.

Is Citius Oncology profitable or losing money?

As of the last Citius Oncology earnings report, Citius Oncology is currently losing money. Citius Oncology's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$42.51 million, a 63.62% increase year over year.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.